Rigel PharmaceuticalsRIGL
13F holders, Q1 2025 (March 31)6holders
1new positions
1sold out
$17.34avg. 13F price*
At the end of Q1 2025, 6 institutions reported holding Rigel Pharmaceuticals Inc. (RIGL) in their 13F filings, unchanged from Q4 2024. 1 opened new positions and 1 sold out. The largest holders were Farther Finance Advisors, LLC ($12K), Versant Capital Management, Inc ($2K) and EverSource Wealth Advisors, LLC ($1K).
- Company
- Rigel Pharmaceuticals Inc.
- CUSIP
- 766559603
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $180 |
| Exits | 1 | $6K |
All 13F filers, Q4 2024 → Q1 2025: 63 shares bought and 356 shares sold, net −293 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Farther Finance Advisors, LLC | 0.00% | Add +4.2% | 695 | $12K |
| Versant Capital Management, Inc | 0.00% | Add +7.3% | 132 | $2K |
| EverSource Wealth Advisors, LLC | 0.00% | Add +25.4% | 79 | $1K |
| Rothschild Investment LLC | 0.00% | New | 10 | $180 |
| Hexagon Capital Partners LLC | 0.00% | No change | 2 | $36 |
| Huntington National Bank | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is RIGL's weight in each manager's 13F, not the share of Rigel Pharmaceuticals Inc. the manager owns.